Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)"



Kosiborod, Mikhail, Cavender, Matthew A, Fu, Alex Z, Wilding, John P ORCID: 0000-0003-2839-8404, Khunti, Kamlesh, Holl, Reinhard W, Norhammar, Anna, Birkeland, Kare I, Jorgensen, Marit Eika, Thuresson, Marcus
et al (show 5 more authors) (2018) Response by Kosiborod et al to Letters Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)". CIRCULATION, 137 (9). 989 - 991.

[img] Text
Response to letters Circulation FINAL.docx - Accepted Version

Download (17kB)
Item Type: Article
Depositing User: Symplectic Admin
Date Deposited: 13 Apr 2018 10:18
Last Modified: 07 May 2021 11:23
DOI: 10.1161/CIRCULATIONAHA.117.031847
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3020123